Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Febuxostat, sold under the brand name Uloric among others, is a medication used long-term to treat gout due to high uric acid levels. It is generally recommended only for people who cannot take allopurinol. It is taken by mouth.
The analysis highlights History and Applications as prominent areas in the source structure around Febuxostat.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Febuxostat shows recurring relationship patterns in the source. For example, Febuxostat → Adenuric, Australia, Donifoxate, Egypt, Europe, Feburic, Goturic, Goutex, In Pakistan, Japan, Latin America, New Zealand, Pakistan, SJG, SOLACE Pharmaceuticals, Uloric, US Another extracted example is Febuxostat → April, Asia, Astellas, China, Europe, European, European Medicines Agency, FDA, February, Ipsen, Japanese, Menarini, Takeda, TAP Pharmaceuticals, Teijin, US. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
allopurinol drug xanthine acid oxidase effects uric recommended use approved side teijin heart-related people increased risk death compared 2009 include
TTTA extracted 89 structured relationships around Febuxostat. Examples in this analysis include Febuxostat → 3D model (JSmol) → Interactive image and Febuxostat → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Febuxostat | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Febuxostat | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Febuxostat | ATC code | M04AA03 (WHO) | 1.00 | infobox |
| Febuxostat | Bioavailability | ≥84% absorbed | 1.00 | infobox |
| Febuxostat | CAS Number | 144060-53-7 N | 1.00 | infobox |
| Febuxostat | ChEBI | CHEBI:31596 | 1.00 | infobox |
| Febuxostat | ChEMBL | ChEMBL1164729 Y | 1.00 | infobox |
| Febuxostat | ChemSpider | 118173 Y | 1.00 | infobox |
| Febuxostat | CompTox Dashboard (EPA) | DTXSID8048650 | 1.00 | infobox |
| Febuxostat | DrugBank | DB04854 N | 1.00 | infobox |
| Febuxostat | ECHA InfoCard | 100.207.329 | 1.00 | infobox |
| Febuxostat | Elimination half-life | ~5–8 hours | 1.00 | infobox |
| Febuxostat | Excretion | Urine (~49%, mostly as metabolites, 3% as unchanged drug); feces (~45%, mostly as metabolites, 12% as unchanged drug) | 1.00 | infobox |
| Febuxostat | Formula | C16H16N2O3S | 1.00 | infobox |
| Febuxostat | IUPHAR/BPS | 6817 | 1.00 | infobox |
| Febuxostat | KEGG | D01206 Y | 1.00 | infobox |
| Febuxostat | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Febuxostat | Legal status | US: ℞-only | 1.00 | infobox |
| Febuxostat | Legal status | EU: Rx-only | 1.00 | infobox |
| Febuxostat | License data | US DailyMed: Febuxostat | 1.00 | infobox |
| Febuxostat | MedlinePlus | a609020 | 1.00 | infobox |
| Febuxostat | Metabolism | via CYP1A1, 1A2, 2C8, 2C9, UGT1A1, 1A8, 1A9 | 1.00 | infobox |
| Febuxostat | Molar mass | 316.38 g·mol−1 | 1.00 | infobox |
| Febuxostat | Pregnancy category | AU: B1 | 1.00 | infobox |
| Febuxostat | Protein binding | 99.2% to albumin | 1.00 | infobox |
| Febuxostat | PubChem CID | 134018 | 1.00 | infobox |
| Febuxostat | Routes of administration | By mouth | 1.00 | infobox |
| Febuxostat | Trade names | Uloric, Adenuric, others | 1.00 | infobox |
| Febuxostat | UNII | 101V0R1N2E | 1.00 | infobox |
The concept neighborhoods around Febuxostat bring nearby vocabulary together. In this analysis, examples include Allopurinol, Clinical and Drug. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Febuxostat, one of the stronger structural bridges in this analysis connects Febuxostat with Pharmacology. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Febuxostat to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Febuxostat · EN edition · Analysis: TopicsToTalkAbout